Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-002520

COO, GENERAL COUNSEL &CORP SEC gave up 459 shares (to pay taxes)

  • COO, GENERAL COUNSEL &CORP SEC acquired 1,562 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC 2020-10-30 Option exercise +1,562 7,853 D
Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC 2020-10-30 Shares withheld for taxes −459 $2.53 $1,161 7,394 D
Derivatives
Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC 2020-10-30 Option exercise · Restricted Stock Units −1,562 14,063 D
Loading xslF345X03/form4-11022020_041102.xml…